Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Beltropolis Boy who wrote (900)	3/15/1999 11:54:00 AM
From: jerryriti	Read Replies (1) \| Respond to of 1686

>decided to switch gears and become a fully integrated pharmaceutical company> Having been an investor in BGEN since 1983, I can remember making buys of the stock at below $4/share! In the early days, the street hated Biogen claiming they were selling their future via licensing agreements and would not ever realize their stated goal of becoming a fully integrated drug company The reason for my post is to highlight the fact that even in those days Biogen was committed to becoming a fully integrated pharmaceutical company. Oh well, if you are going to do an analysis of a company, I guess you are allowed some poetic license!